Login / Signup

TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.

Frone VandewieleAndy PironetGriet JacobsMiklos KecskésJörg W WegenerSara KerselaersLio HendrikxJoren VerelstKoenraad PhilippaertWouter OosterlinckAndrei SegalEvy Van Den BroeckSilvia PintoSilvia Giuliana PrioriStephan E LehnartBernd NiliusThomas VoetsRudi Vennekens
Published in: European heart journal (2022)
The presented data establish that TRPM4 represents a novel target in the prevention and treatment of Ca2+-dependent triggered arrhythmias.
Keyphrases
  • congenital heart disease
  • signaling pathway
  • electronic health record
  • protein kinase
  • big data